New Enterprise Associates's Therapeutics Portfolio

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Brenig Therapeutics develops therapies for neurodegenerative disorders.

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.

Pathos is a biotechnology company that leverages AI to accelerate oncology drug development.

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Amber Therapeutics develops the next-generation of bioelectrical therapies.

Woebot Health provides behavioral health solutions and prescription for adolescent and postpartum depression.

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

Abcuro develops immunotherapies to treat autoimmunity and cancer.

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

SetPoint Medical provides a device-based therapy for rheumatoid arthritis.

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

Tune Therapeutics is an epigenetic programming platform for the treatment of disease.

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Launchpad Therapeutics operates as an antibody-focused precision oncology company.

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.

Cardionomic is a medical device developer that treats reduced cardiac output.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Charm Therapeutics designs and develops small-molecule therapeutics that target the interaction between menin and the KMT2A protein.

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.